Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
Titel:
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
Auteur:
Zeng, Qinghe Klein, Christophe Caruso, Stefano Maille, Pascale Allende, Daniela S Mínguez, Beatriz Iavarone, Massimo Ningarhari, Massih Casadei-Gardini, Andrea Pedica, Federica Rimini, Margherita Perbellini, Riccardo Boulagnon-Rombi, Camille Heurgué, Alexandra Maggioni, Marco Rela, Mohamed Vij, Mukul Baulande, Sylvain Legoix, Patricia Lameiras, Sonia Bruges, Léa Gnemmi, Viviane Nault, Jean-Charles Campani, Claudia Rhee, Hyungjin Park, Young Nyun Iñarrairaegui, Mercedes Garcia-Porrero, Guillermo Argemi, Josepmaria Sangro, Bruno D'Alessio, Antonio Scheiner, Bernhard Pinato, David James Pinter, Matthias Paradis, Valérie Beaufrère, Aurélie Peter, Simon Rimassa, Lorenza Di Tommaso, Luca Vogel, Arndt Michalak, Sophie Boursier, Jérôme Loménie, Nicolas Ziol, Marianne Calderaro, Julien